EBITDA Margin: Earnings before interest, taxes, depreciation and amortization as a portion of total revenue. Calculated as: EBITDA / Total Revenues
Kyntra Bio Inc (KYNB) had EBITDA Margin of -702.16% for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$6.44M |
|
$183.45M |
|
$0.56M |
|
$5.88M |
|
$52.34M |
|
$-45.90M |
|
$-12.40M |
|
$-58.29M |
|
$-58.29M |
|
$-58.20M |
|
$-58.20M |
|
$183.45M |
|
$-58.20M |
|
$-45.90M |
|
$-45.22M |
|
4.04M |
|
4.04M |
|
$45.37 |
|
$45.37 |
|
| Balance Sheet Financials | |
$99.07M |
|
-- |
|
$20.52M |
|
$119.59M |
|
$29.24M |
|
-- |
|
$107.36M |
|
$136.60M |
|
$-17.01M |
|
$-17.00M |
|
$-17.00M |
|
4.05M |
|
| Cash Flow Statement Financials | |
$-4.77M |
|
$35.42M |
|
$-86.03M |
|
$102.18M |
|
$47.87M |
|
$-54.31M |
|
$6.58M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.39 |
|
-- |
|
-- |
|
-- |
|
-- |
|
91.37% |
|
-712.66% |
|
-712.66% |
|
|
EBITDA Margin |
-702.16% |
-905.19% |
|
2848.63% |
|
$-4.81M |
|
-- |
|
-- |
|
-- |
|
0.05 |
|
0.15 |
|
29.81 |
|
12.24 |
|
342.27% |
|
342.28% |
|
-48.67% |
|
342.28% |
|
$-4.20 |
|
$-1.19 |
|
$-1.18 |
|